Immune thrombocytopenic purpura cases following COVID-19 vaccination.

Main Article Content

Annalisa Condorelli
Uros Markovic
Roberta Sciortino
Mary Ann Di Giorgio
Daniela Nicolosi
Gaetano Giuffrida

Keywords

COVID 19, Immune thrombocytopenic purpura, Adverse event, Vaccination

Abstract

Not requested.

Downloads

Download data is not yet available.
Abstract 432 | PDF Downloads 123 HTML Downloads 74

References

1. Rodeghiero F. Practical recommendations for the management of patients with ITP during the COVID-19 Pandemic. Mediterr J Hematol Infect Dis. 2021;13(1). doi:10.4084/mjhid.2021.032
2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. doi:10.1056/nejmoa2034577
3. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi:10.1016/S0140-6736(20)32661-1
4. Perricone C, Ceccarelli F, Nesher G, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014;60(2-3):226-235. doi:10.1007/s12026-014-8597-x
5. Helms JM, Ansteatt KT, Roberts JC, et al. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med. 2021;Volume 12:221-224. doi:10.2147/jbm.s307047
6. Malayala S V, Mohan G, Vasireddy D, Atluri P. Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine. Cureus. 2021. doi:10.7759/cureus.14099
7. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021. doi:10.1002/ajh.26132
8. Candelli Marcello, Rossi Elena, Valletta Federico, De Stefano Valerio FF. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br Soc Haematol John Wiley Sons Ltd. 2021.
9. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021. doi:10.1016/j.vaccine.2021.04.054
10. Cines DB, Bussel JB. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021. doi:10.1056/nejme2106315